Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
68.19B | 65.76B | 61.34B | 57.89B | 58.09B | Gross Profit |
4.66B | 4.68B | 4.69B | 3.86B | 4.41B | EBIT |
2.82B | 2.62B | 2.71B | 2.09B | 2.67B | EBITDA |
4.83B | 3.23B | 4.40B | 3.10B | 4.83B | Net Income Common Stockholders |
1.19B | 737.00M | 1.48B | 690.00M | 971.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
4.67B | 4.45B | 4.65B | 3.70B | 5.42B | Total Assets |
47.04B | 46.13B | 49.35B | 45.51B | 53.15B | Total Debt |
14.84B | 15.08B | 15.36B | 15.67B | 17.79B | Net Debt |
12.50B | 12.61B | 13.01B | 13.16B | 13.65B | Total Liabilities |
35.37B | 33.90B | 33.71B | 33.45B | 39.78B | Stockholders Equity |
11.67B | 12.24B | 15.66B | 12.08B | 13.39B |
Cash Flow | Free Cash Flow | |||
2.45B | 2.56B | 2.61B | -737.00M | -1.10B | Operating Cash Flow |
3.84B | 3.81B | 3.79B | 640.00M | 108.00M | Investing Cash Flow |
-1.70B | -790.00M | -1.77B | 6.13B | 2.34B | Financing Cash Flow |
-1.86B | -3.19B | -2.23B | -7.84B | -1.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $762.32B | 39.85 | 22.23% | 0.90% | 5.07% | 25.86% | |
78 Outperform | $433.55B | 56.95 | 32.89% | 0.47% | 6.13% | 12.14% | |
75 Outperform | $14.75B | 27.99 | 32.33% | ― | 2.67% | 2.72% | |
73 Outperform | $46.26B | 19.42 | 26.59% | 1.78% | -1.94% | 23.94% | |
64 Neutral | $9.20B | 14.61 | 4.34% | 185.58% | 3.95% | 5.80% | |
62 Neutral | $29.67B | 14.64 | 15.35% | 3.25% | ― | ― | |
60 Neutral | $44.00B | 10.76 | 29.12% | 4.62% | -0.79% | -0.90% |